Xmoor Pharma and Royal Free London NHS Foundation Trust have patrnered to build a seamless, scalable pathway for CGT ...

Marks Breyanzi’s fourth indication in Europe, adding to existing approvals for several aggressive B-cell lymphomas.

BioMed X has launched a new collaborative research project with AbbVie, hosted at the BioMed X Institute in New Haven, ...

AstraZeneca is investing $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes an ...

Novartis is expanding its operations in North Carolina, creating a new flagship manufacturing hub with end-to-end ...

The Future of Oral Solids explores how innovation, advanced manufacturing, and integrated CDMO partnerships are reshaping the ...

AGC Biologics has entered a new manufacturing agreement with AAVantgarde, marking AGC Biologics’ latest advancement in the ...

Alex Mitchell, Vice President, Operations, Sentry BioPharma Services, discusses the growing use of FTZs by pharmaceutical ...

Agenus Inc., an immune-oncology company, has appointed José Iglesias, M.D. as Chief Medical Affairs Officer.

Debiopharm has launched the IDEAL Japan initiative, a new program designed to provide financial support to Japanese academic ...

Sonoma Biotherapeutics Inc. has appointed Stephen Dilly, former President and CEO of Codexis Inc., and current Chair of the ...

Celltrion announced that the European Commission (EC) has granted marketing authorization for Remsima IV (intravenous) liquid ...